Controlling and monitoring stem cell safety in vivo in an experimental rodent model

Stem Cells

Volumn 32, Issue 11, 2014, Pages 2833-2844

  Leten, Cindy ^a,b   Roobrouck, Valerie D ^c   Struys, Tom ^a,d   Burns, Terry C ^e   Dresselaers, Tom ^a,b   Vande Velde, G ^a,b   Santermans, Jeanine ^d   Nigro, Antonio Lo ^c   Ibrahimi, Abdelilah ^f,g   Gijsbers, Rik ^f,g   Eggermont, Kristel ^c   Lambrichts, Ivo ^d   Verfaillie, Catherine M ^c   Himmelreich, Uwe ^a,b  

^a DEPARTMENT OF IMAGING AND PATHOLOGY   (Belgium)

^b KU Leuven   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d HASSELT UNIVERSITY   (Belgium)

^e STANFORD UNIVERSITY   (United States)

^f DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^g KU LEUVEN   (Belgium)

Author keywords

Adult stem cells; Gene expression; In vivo optical imaging; Magnetic resonance imaging; Syngeneic engraftment

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GANCICLOVIR; GREEN FLUORESCENT PROTEINS; LUCIFERASES, FIREFLY; OCTAMER TRANSCRIPTION FACTOR-3;

ANIMALS; BRAIN; CELL LINE; CYTOLOGY; MAGNETIC RESONANCE IMAGING; METABOLISM; MICE; MODELS, ANIMAL; RABBITS; RATS; STEM CELLS;

ANIMALS; BRAIN; CELL LINE; GANCICLOVIR; GREEN FLUORESCENT PROTEINS; LUCIFERASES, FIREFLY; MAGNETIC RESONANCE IMAGING; MICE; MODELS, ANIMAL; OCTAMER TRANSCRIPTION FACTOR-3; RABBITS; RATS; STEM CELLS;

EID: 84907905139     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1819     Document Type: Article

References (27)

1. Gursel DB, Berry N, Boockvar JA,. Therapeutic stem cells encapsulated in a synthetic extracellular matrix selectively kill tumor cells, delay tumor growth, and increase survival in a mouse resection model of malignant glioma. Neurosurgery 2012; 70: N17-N19.
2. Burns TC, Steinberg GK,. Stem cells and stroke: Opportunities, challenges and strategies. Expert Opin Biol Ther 2011; 11: 447-461.
3. Bang OY, Lee JS, Lee PH, et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57: 874-882.
4. Arnhold S, Klein H, Semkova I, et al. Neurally selected embryonic stem cells induce tumor formation after long-term survival following engraftment into the subretinal space. Invest Ophthalmol Vis Sci 2004; 45: 4251-4255.
5. Blum B, Benvenisty N,. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 2009; 8: 3822-3830.
6. Cunningham JJ, Ulbright TM, Pera MF, et al. Lessons from human teratomas to guide development of safe stem cell therapies. Nat Biotechnol 2012; 30: 849-857.
7. Ulloa-Montoya F, Kidder BL, Pauwelyn KA, et al. Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol 2007; 8: R163.
8. Roobrouck VD, Clavel C, Jacobs SA, et al. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 2011; 29: 871-882.
9. Verfaillie CM,. Multipotent adult progenitor cells: An update. Novartis Found Symp 2005; 265: 55-61; discussion 61-65, 92-97.
10. Lo Nigro A, Geraerts M, Notelaers T, et al. MAPC culture conditions support the derivation of cells with nascent hypoblast features from bone marrow and blastocysts. J Mol Cell Biol 2012; 4: 423-426.
11. Kovacsovics-Bankowski M, Mauch K, Raber A, et al. Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells. Cytotherapy 2008; 10: 730-742.
12. Jacobs AH, Winkeler A, Hartung M, et al. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes. Hum Gene Ther 2003; 14: 277-297.
13. Kucerova L, Altanerova V, Matuskova M, et al. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007; 67: 6304-6313.
14. Li S, Tokuyama T, Yamamoto J, et al. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther 2005; 12: 600-607.
15. Miletic H, Fischer Y, Litwak S, et al. Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol Ther 2007; 15: 1373-1381.
16. Miletic H, Fischer YH, Giroglou T, et al. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma. Clin Cancer Res 2007; 13: 6761-6768.
17. Breyer A, Estharabadi N, Oki M, et al. Multipotent adult progenitor cell isolation and culture procedures. Exp Hematol 2006; 34: 1596-1601.
18. Ibrahimi A, Vande Velde G, Reumers V, et al. Highly efficient multicistronic lentiviral vectors with peptide 2A sequences. Hum Gene Ther 2009; 20: 845-860.
19. Subramanian K, Geraerts M, Pauwelyn KA, et al. Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow. Methods Mol Biol 2010; 636: 55-78.
20. Maes W, Rosas GG, Verbinnen B, et al. DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma. Neuro Oncol 2009; 11: 529-542.
21. Le Bihan D,. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4: 469-480.
22. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998; 95: 379-391.
23. Rosland GV, Svendsen A, Torsvik A, et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 2009; 69: 5331-5339.
24. Fillat C, Carrio M, Cascante A, et al. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: Fifteen years of application. Curr Gene Ther 2003; 3: 13-26.
25. Vile RG, Diaz RM, Castleden S, et al. Targeted gene therapy for cancer: Herpes simplex virus thymidine kinase gene-mediated cell killing leads to anti-tumour immunity that can be augmented by co-expression of cytokines in the tumour cells. Biochem Soc Trans 1997; 25: 717-722.
26. Vile RG, Castleden S, Marshall J, et al. Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression. Int J Cancer 1997; 71: 267-274.
27. Braumuller H, Wieder T, Brenner E, et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 2013; 494: 361-365.